(2S)-4-azido-3-[(2S,3S)-3-hydroxybutan-2-yl]oxybutane-1,2-diol

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: (2S)-4-azido-3-[(2S,3S)-3-hydroxybutan-2-yl]oxybutane-1,2-diol
• 化学式: C8H17N3O4
• 分子量: 219.24
• InChiKey: FUICLQAMBPSVFP-FKMOCYPUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  84.3
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• REVERSIBLE NATURAL PRODUCT GLYCOSYLTRANSFERASE-CATALYZED REACTIONS, COMPOUNDS AND RELATED METHODS
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：US20150141294A1

  公开（公告）日：2015-05-21

  The present invention relates to methods of use of glycosyltransferases and related novel compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomolecules and numerous one-pot reactions for generation of new biomolecules having varied backbones such as enediynes, vancomycins, bleomycins, anthracyclines, macrolides, pluramycins, aureolic acids, indolocarbazoles, aminglycosides, glycopeptides, polyenes, coumarins, benzoisochromanequinones, calicheamicins, erythromycin, avermectins, ivermectins, angucyclines, cardiac glycosides, steroids or flavinoids. In preferred embodiments, the invention specifically relates to biosynthesis of anticancer (the enediyne calicheamicin, CLM), anthelmintic agents (the macrolides avermectin, ivermectin and erythromycin) and antibiotic (the glycopeptide vancomycin, VCM) natural product-based drugs developed by reversible, bidirectional glycosyltransferase-catalyzed reactions.
• US8841092B2
  申请人：——

  公开号：US8841092B2

  公开（公告）日：2014-09-23
• US9469864B2
  申请人：——

  公开号：US9469864B2

  公开（公告）日：2016-10-18